These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 17217540)
21. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance]. Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690 [TBL] [Abstract][Full Text] [Related]
22. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast]. Niu F; Wang L; Zhang W; Lyu S; Niu Y Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593 [TBL] [Abstract][Full Text] [Related]
23. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Rakha EA; El-Sayed ME; Green AR; Paish EC; Lee AH; Ellis IO Histopathology; 2007 Mar; 50(4):434-8. PubMed ID: 17448018 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528 [TBL] [Abstract][Full Text] [Related]
25. Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20. Jangir H; Nambirajan A; Seth A; Sahoo RK; Dinda AK; Nayak B; Kaushal S Ann Diagn Pathol; 2019 Dec; 43():151397. PubMed ID: 31494492 [TBL] [Abstract][Full Text] [Related]
26. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Rakha EA; El-Rehim DA; Paish C; Green AR; Lee AH; Robertson JF; Blamey RW; Macmillan D; Ellis IO Eur J Cancer; 2006 Dec; 42(18):3149-56. PubMed ID: 17055256 [TBL] [Abstract][Full Text] [Related]
27. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35. Nassar A; Sussman ZM; Lawson D; Cohen C Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580 [TBL] [Abstract][Full Text] [Related]
28. P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Paredes J; Lopes N; Milanezi F; Schmitt FC Virchows Arch; 2007 Jan; 450(1):73-80. PubMed ID: 17123107 [TBL] [Abstract][Full Text] [Related]
29. A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma. Pillay K; McCleod H; Chetty R; Hall P World J Surg Oncol; 2011 Mar; 9():31. PubMed ID: 21410943 [TBL] [Abstract][Full Text] [Related]
30. The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology. Rakha EA; Gill MS; El-Sayed ME; Khan MM; Hodi Z; Blamey RW; Evans AJ; Lee AH; Ellis IO Breast Cancer Res Treat; 2009 Mar; 114(2):243-50. PubMed ID: 18404368 [TBL] [Abstract][Full Text] [Related]
31. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas. Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639 [TBL] [Abstract][Full Text] [Related]
32. Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma. Silver SA; Tavassoli FA Histopathology; 2000 Jun; 36(6):505-14. PubMed ID: 10849092 [TBL] [Abstract][Full Text] [Related]
33. Basal-like immunophenotype markers and prognosis in early breast cancer. Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B Tumori; 2010; 96(6):966-70. PubMed ID: 21388060 [TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic features and prognostic significance of basal-like breast cancer]. Liu H; Fan QH; Li X; Liu GZ Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):316-22. PubMed ID: 19575874 [TBL] [Abstract][Full Text] [Related]
35. CK14 Expression Identifies a Basal/Squamous-Like Type of Papillary Non-Muscle-Invasive Upper Tract Urothelial Carcinoma. Jung M; Jang I; Kim K; Moon KC Front Oncol; 2020; 10():623. PubMed ID: 32391279 [No Abstract] [Full Text] [Related]
36. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706 [TBL] [Abstract][Full Text] [Related]
37. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664 [TBL] [Abstract][Full Text] [Related]
38. Mesothelial markers in high-grade breast carcinoma. Duhig EE; Kalpakos L; Yang IA; Clarke BE Histopathology; 2011 Nov; 59(5):957-64. PubMed ID: 22092407 [TBL] [Abstract][Full Text] [Related]
39. Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin. Dogu GG; Ozkan M; Ozturk F; Dikilitas M; Er O; Ozturk A Med Oncol; 2010 Mar; 27(1):34-9. PubMed ID: 19156550 [TBL] [Abstract][Full Text] [Related]
40. Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific type. Hamilton LJ; Evans AJ; Pinder SE; James JJ; Gutteridge E; Cornford EJ; Burrell HC; Chan SY; Robertson JF; Cheung KL Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):119-24. PubMed ID: 15074735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]